https://www.watson-int.cn/wp-content/uploads/2024/07/atomoxetine-ep-impurity-f.jpg5101200great_watson-inthttps://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpggreat_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atomoxetine EP Impurity F CAS号 2727370-25-2
https://www.watson-int.cn/wp-content/uploads/2024/07/atomoxetine-ep-impurity-h.jpg5101200great_watson-inthttps://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpggreat_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atomoxetine EP Impurity H CAS号 42142-52-9
https://www.watson-int.cn/wp-content/uploads/2024/07/buspirone-ep-impurity-e-na-salt.jpg6891200great_watson-inthttps://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpggreat_watson-int2024-07-07 00:17:212024-07-07 00:17:21Buspirone EP Impurity E (Na salt) CAS号 N/A
https://www.watson-int.cn/wp-content/uploads/2024/07/buspirone-ep-impurity-g.jpg5111200great_watson-inthttps://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpggreat_watson-int2024-07-07 00:17:212024-07-07 00:17:21Buspirone EP Impurity G CAS号 84746-24-7
https://www.watson-int.cn/wp-content/uploads/2024/07/celecoxib-ep-impurity-a.jpg5111200great_watson-inthttps://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpggreat_watson-int2024-07-07 00:17:212024-07-07 00:17:21Celecoxib EP Impurity A CAS号 170570-01-1
https://www.watson-int.cn/wp-content/uploads/2024/07/atomoxetine-ep-impurity-f.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atomoxetine EP Impurity F CAS号 2727370-25-2
https://www.watson-int.cn/wp-content/uploads/2024/07/atomoxetine-ep-impurity-h.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atomoxetine EP Impurity H CAS号 42142-52-9
https://www.watson-int.cn/wp-content/uploads/2024/07/buspirone-ep-impurity-e-na-salt.jpg
689
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Buspirone EP Impurity E (Na salt) CAS号 N/A
https://www.watson-int.cn/wp-content/uploads/2024/07/buspirone-ep-impurity-g.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Buspirone EP Impurity G CAS号 84746-24-7
https://www.watson-int.cn/wp-content/uploads/2024/07/celecoxib-ep-impurity-a.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Celecoxib EP Impurity A CAS号 170570-01-1
https://www.watson-int.cn/wp-content/uploads/2024/07/celecoxib-2-methyl-analog.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Celecoxib 2-Methyl Analog CAS号 170569-99-0
https://www.watson-int.cn/wp-content/uploads/2024/07/celecoxib-hydroxymethyl-analog.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Celecoxib Hydroxymethyl Analog CAS号 170571-00-3
https://www.watson-int.cn/wp-content/uploads/2024/07/azilsartan.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Azilsartan CAS号 147403-03-0
https://www.watson-int.cn/wp-content/uploads/2024/07/atazanavir.jpg
580
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atazanavir CAS号 198904-31-3
https://www.watson-int.cn/wp-content/uploads/2024/07/atazanavir-impurity-2.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:17:212024-07-07 00:17:21Atazanavir Impurity 2 CAS号 198904-33-5